Mikael Dolsten is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 14,220 shares of RCKT, which is worth approximately $108,498. The most recent transaction as insider was on Mar 05, 2025, when has been sold 14,220 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.2K
n/a 3M change
n/a 12M change
Total Value Held $108,498

Mikael Dolsten Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 05 2025
BUY
Other acquisition or disposition
-
14,220 Added 50.0%
14,220 Common Stock

Also insider at

PFE
PFIZER INC Healthcare
A
AGILENT TECHNOLOGIES, INC. Healthcare
KPTI
Karyopharm Therapeutics Inc. Healthcare
MD

Mikael Dolsten

New York, NY

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT